Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 2 of 2: GR metrics. - Dataset (ID:20365)

Filter results: >>>>
Cell line Drug name Experimental replicate Timepoint Curve type (GR values) Curve type (relative cell counts) Experiment name Number of concentrations Cell doublings (DMSO control) GR50 GRmax GR_AOC GEC50 GRinf Hill slope (GR values) R-squared sigmoid fit (GR values) P-value sigmoid fit (GR values) R-squared flat fit (GR values) IC50 Emax AUC EC50 Einf Hill slope (relative cell counts) R-squared sigmoid fit (relative cell counts) P-value sigmoid fit (relative cell counts) R-squared flat fit (relative cell counts)
BT-549 Dactolisib 3 72
sigmoid
sigmoid
BT549 dactolisib 0 3 72
8 1.801
0.0058
-0.00929
0.751
0.00579
0.000747
0.866
0.994
2.41e-07
NA
0.011
0.282
0.442
0.00425
0.29
0.909
0.995
1.54e-07
NA
Hs 578T Omipalisib 1
sigmoid
sigmoid
Hs578T omipalisib 1
8 2.079
0.00552
-0.546
0.842
0.17
-1.0
0.321
0.98
8.1e-06
NA
0.0079
0.0459
0.351
0.0079
0.0
0.369
0.984
4.12e-06
NA
BT-20 Dactolisib 2 72
sigmoid
sigmoid
BT20 dactolisib 0 2 72
8 1.727
0.00497
-0.212
0.896
0.00652
-0.186
1.17
0.995
1.45e-07
NA
0.00801
0.2
0.382
0.00505
0.211
1.19
0.994
2.07e-07
NA
HCC70 Omipalisib 1 72
sigmoid
sigmoid
HCC70 omipalisib 0 1 72
8 1.358
0.00496
-0.785
1.14
0.0157
-0.775
0.812
0.989
1.34e-06
NA
0.0123
0.0486
0.349
0.011
0.0462
0.833
0.984
3.73e-06
NA
Hs 578T Trametinib 1
sigmoid
sigmoid
Hs578T trametinib 1
8 2.044
0.00353
-0.00904
0.765
0.00516
-0.0906
0.437
0.992
4.85e-07
NA
0.00661
0.238
0.385
0.00213
0.201
0.456
0.993
3e-07
NA
BT-20 Omipalisib 2 72
sigmoid
sigmoid
BT20 omipalisib 0 2 72
8 1.717
0.00324
-0.799
1.1
0.00361
-0.354
4.99
0.808
0.00704
NA
0.00518
0.0194
0.291
0.00429
0.111
1.34
0.968
3.16e-05
NA
BT-20 Torin2 2 72
sigmoid
sigmoid
BT20 Torin2 0 2 72
8 1.733
0.00315
-0.761
0.992
0.0484
-0.95
0.389
0.949
0.000131
NA
0.00804
0.0252
0.336
0.00642
0.0613
0.583
0.974
1.77e-05
NA